Imai K - Search Results

1

2-methoxyestradiol, an endogenous mammalian metabolite, radiosensitizes colon carcinoma cells through c-Jun NH2-terminal kinase activation.

Zou H, Adachi M, Imai K, Hareyama M, Yoshioka K, Zhao S, Shinomura Y. Zou H, et al. Among authors: imai k. Clin Cancer Res. 2006 Nov 1;12(21):6532-9. doi: 10.1158/1078-0432.CCR-06-0678. Clin Cancer Res. 2006. PMID: 17085668

2

Combination of tumor necrosis factor-alpha with sulindac augments its apoptotic potential and suppresses tumor growth of human carcinoma cells in nude mice.

Yasui H, Adachi M, Imai K. Yasui H, et al. Among authors: imai k. Cancer. 2003 Mar 15;97(6):1412-20. doi: 10.1002/cncr.11210. Cancer. 2003. PMID: 12627504 Free article.

3

Synergistic effect of histone deacetylase inhibitors FK228 and m-carboxycinnamic acid bis-hydroxamide with proteasome inhibitors PSI and PS-341 against gastrointestinal adenocarcinoma cells.

Adachi M, Zhang Y, Zhao X, Minami T, Kawamura R, Hinoda Y, Imai K. Adachi M, et al. Among authors: imai k. Clin Cancer Res. 2004 Jun 1;10(11):3853-62. doi: 10.1158/1078-0432.CCR-03-0806. Clin Cancer Res. 2004. PMID: 15173094

4

Sulindac enhances the proteasome inhibitor bortezomib-mediated oxidative stress and anticancer activity.

Minami T, Adachi M, Kawamura R, Zhang Y, Shinomura Y, Imai K. Minami T, et al. Among authors: imai k. Clin Cancer Res. 2005 Jul 15;11(14):5248-56. doi: 10.1158/1078-0432.CCR-05-0085. Clin Cancer Res. 2005. PMID: 16033843

5

Histone deacetylase inhibitors enhance phosphorylation of histone H2AX after ionizing radiation.

Zhang Y, Adachi M, Zou H, Hareyama M, Imai K, Shinomura Y. Zhang Y, et al. Among authors: imai k. Int J Radiat Oncol Biol Phys. 2006 Jul 1;65(3):859-66. doi: 10.1016/j.ijrobp.2006.03.019. Int J Radiat Oncol Biol Phys. 2006. PMID: 16751067

6

A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.

Idogawa M, Sasaki Y, Suzuki H, Mita H, Imai K, Shinomura Y, Tokino T. Idogawa M, et al. Among authors: imai k. Clin Cancer Res. 2009 Jun 1;15(11):3725-32. doi: 10.1158/1078-0432.CCR-08-2396. Epub 2009 May 19. Clin Cancer Res. 2009. PMID: 19458054

7

The efficacy of IGF-I receptor monoclonal antibody against human gastrointestinal carcinomas is independent of k-ras mutation status.

Ii M, Li H, Adachi Y, Yamamoto H, Ohashi H, Taniguchi H, Arimura Y, Carbone DP, Imai K, Shinomura Y. Ii M, et al. Among authors: imai k. Clin Cancer Res. 2011 Aug 1;17(15):5048-59. doi: 10.1158/1078-0432.CCR-10-3131. Epub 2011 Jun 3. Clin Cancer Res. 2011. PMID: 21642381

8

Overexpression of BAD preferentially augments anoikis.

Idogawa M, Adachi M, Minami T, Yasui H, Imai K. Idogawa M, et al. Among authors: imai k. Int J Cancer. 2003 Nov 1;107(2):215-23. doi: 10.1002/ijc.11399. Int J Cancer. 2003. PMID: 12949797

9

Combination of tumor necrosis factor-alpha with sulindac in human carcinoma cells in vivo.

Yasui H, Adachi M, Imai K. Yasui H, et al. Among authors: imai k. Ann N Y Acad Sci. 2003 Dec;1010:273-7. doi: 10.1196/annals.1299.047. Ann N Y Acad Sci. 2003. PMID: 15033733

10

Histone deacetylase inhibitors FK228, N-(2-aminophenyl)-4-[N-(pyridin-3-yl-methoxycarbonyl)amino- methyl]benzamide and m-carboxycinnamic acid bis-hydroxamide augment radiation-induced cell death in gastrointestinal adenocarcinoma cells.

Zhang Y, Adachi M, Zhao X, Kawamura R, Imai K. Zhang Y, et al. Among authors: imai k. Int J Cancer. 2004 Jun 10;110(2):301-8. doi: 10.1002/ijc.20117. Int J Cancer. 2004. PMID: 15069698

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,182 results

Search Page

Filters